OKYO Pharma Limited Sponsored ADR's total assets for Q4 2025 were $3.68M, an increase of 29.99% from the previous quarter. OKYO total liabilities were $9.23M for the fiscal quarter, a -8.23% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.